Research Paper Volume 16, Issue 1 pp 285—298
MAGE-A11 is a potential prognostic biomarker and immunotherapeutic target in gastric cancer
Figure 7. The relationship between MAGE-A11 expression and the tumour microenvironment. (A) Stromalscore, Immunescore and ESTIMATE score differences between MAGE-A11 high and low expression groups. (B) Proportion of tumor-infiltrating immune cells in each sample. (C) Relationship between tumor-infiltrating cells.